Effect of cyclosporine A formulations on bovine corneal absorption: ex-vivo study

References

• Al Khouri N., Roblot-Treupel L., Fessi H., Devissaguet J. P., Puisieux F. Development of a new process for the manufacture of poly-isobutyl-cyanoacrylate nanocapsules. International Journal of Pharmaceutics 1986; 28: 125–132
   Web of Science ®Google Scholar
• Alonso M. J., Calvo P., Vila Jato J. L., Lopez M. I., Llorente J., Pastor J. C. Increased ocular corneal uptake of drugs using poly-ε-caprolactone nanocapsules and nanoemulsion. Proceedings of the International Symposium on Controlled Release of Bioactive Material 1995; 22: 1303
   Google Scholar
• Belin M. W., Bouchard C. S., Phillips T. M. Update on topical Cyclosporine A: Background, Immunology, and Pharmacology. Cornea 1990; 9(3)184–195
   PubMed Web of Science ®Google Scholar
• Ben Ezra D., Peer J., Brodsky M., Cohen E. Cyclosporine A eye drops for the treatment of severe vernal keratoconjunctivitis. American Journal of Ophthalmology 1986; 101: 278–282
   PubMed Web of Science ®Google Scholar
• Ben Ezra D., Maftzir G., de Courten C., Timonen P. Ocular penetration of cyclosporine A. III: the human eye. British Journal of Ophthalmology 1990; 74: 350–352
   PubMed Web of Science ®Google Scholar
• Benitez-del-Castillo J. M., del Aguila C., Duran S., Hernandez J., Garcia Sanchez J. Influence of topically applied Cyclosporine in olive oil on corneal epithelium permeability. Cornea 1994; 13(2)136–140
   PubMed Web of Science ®Google Scholar
• Bonduelle S., Pimienta C., Benoit J. P., Lenaerts V. Body distribution in mice of intravenously injected radiolabelled Cyclosporine associated with polyisohexylcyanoacrylate nanocapsules or nanospheres. European Journal of Biopharmacy 1995; 41(1)27–30
   Google Scholar
• Chu J. S., Danny M. Y., Amidon G. L., Weiner N. D., Goldberg A. H. Viscoelastic properties of polyacrylic acid gels in mixed solvents. Pharmaceutical Research 1992; 9(12)1659–1663
   PubMed Web of Science ®Google Scholar
• Diaz-Llopis M., Menezo J. L. Penetration of 2% Cyclosporin eyedrops into human aqueous humor. British Journal of Ophthalmology 1989; 73: 600–603
   PubMed Web of Science ®Google Scholar
• Duchêne D., Touchard F., Peppas N. A. Pharmaceutical and medical aspects of bioadhesive systems for drug administration. Drug Development and Industrial Pharmacy 1988; 14(2&3)283–318
   Web of Science ®Google Scholar
• Foets B., Missotten L., Vanderveeren P., Goosens W. Prolonged survival of allogenic corneal grafts in rabbits treated with topically applied cyclosporin A: systemic absorption and local immunosuppressive effect. British Journal of Ophthalmology 1985; 69: 600–603
   PubMed Web of Science ®Google Scholar
• Gregory C. R., Hietala S. K., Pedersen N. C., Gregory T. A., Floyd-Hawkins K. A., Patz J. D. Cyclosporine pharmacokinetics in cats following topical ocular administration. Transplantation 1989; 47(3)516–519
   PubMed Web of Science ®Google Scholar
• Goichot-Bonnat L., Chemla P., Pouliquen Y. Cyclosporine A collyre dans la prévention du rejet de greffe de cornée à haut risque. II. Résultats cliniques. Journal François d'Ophtalmologie 1987; 10(3)213–217
   PubMedGoogle Scholar
• Gurny R., Boye T., Ibrahim H. Ocular therapy with nanoparticulate systems for controlled drug delivery. Journal of Controlled Release 1985; 2: 353–361
   Google Scholar
• Harper C. A., Khoobehi B., Peyman G. A., Gebhardt B. M., Dunlap W. A. Bioavailability of microspheres-entrapped Cyclosporine in the cornea and aqueous humour of rabbits. International Journal of Ophthalmology 1993; 17(6)337–340
   Google Scholar
• Holland E. J., Olsen T. W., Ketcham J. M., Florine C., Krachmer J. H., Purcell J. J., Lam S., Tessler H. H. Topical Cyclosporin A in the treatment of anterior segment inflammatory disease. Cornea 1993; 12(5)413–419
   PubMed Web of Science ®Google Scholar
• Hunter P. A., Wilhelmus K. R., Rice N. S. C., Jones B. R. Cyclosporin A applied topically to the recipient eye inhibits corneal graft rejection. Clinical Experimental Immunology 1981; 45: 173–177
   PubMed Web of Science ®Google Scholar
• Kalsi G. S., Gudauskas G., Bussanich N., Freeman D. J., Rootman J. Ocular pharmacokinetics of subconjunctivally administered cyclosporine A in the rabbit. Canadian Journal of Ophthalmology 1991; 26(4)200–205
   PubMed Web of Science ®Google Scholar
• Kanpolat A., Batioglu F., Vilmaz M., Akbas F. Penetration of cyclosporine into the rabbit cornea and aqueous humor after topical drop and collagen shield administration. Clao Journal 1994; 20(2)119–122
   PubMedGoogle Scholar
• Kaswan R. L. Intraocular penetration of topically applied cyclosporine A. Transplantation Proceedings 1988; 20(2)suppl. 2: 650–655
   Web of Science ®Google Scholar
• Losa C., Marchal-Heussler L., Orallo F., Vila Jato J. L., Alonso M. J. Design of new formulations for topical ocular administration: Polymeric nanocapsules containing Metipranolol. Pharmaceutical Research 1993; 10(1)80–87
   PubMed Web of Science ®Google Scholar
• Mahlberg K., Usitalo R. J., Gebhardt B., Kaufman H. E. Prevention of experimental corneal allograft rejection in rabbits using cyclosporin-collagen shields. Greafes Archive for Clinical and Experimental Ophthalmology 1991; 229(1)69–74
   PubMed Web of Science ®Google Scholar
• Milani J. K., Pleyer U., Dukes A., Chou H. J., Lutz S., Ruckert D. Prolongation of corneal allograft survival with liposome-encapsulated cyclosporine A in the rat eye. Ophthalmology 1993; 100(6)890–896
   PubMed Web of Science ®Google Scholar
• Minguez E., Tiestos M. T., Cristobal J. A., Castillo J., Dapena M. P., Palomar A. Absorption intra-oculaire du collyre cyclosporine A. Journal Franfais d'Ophtalmologie 1992; 15(4)263–267
   PubMed Web of Science ®Google Scholar
• Mosteller M. W., Gebhardt B. M., Hamilton A. M., Kaufman H. E. Penetration of topical cyclosporine A into the rabbit cornea, aqueous humor and serum. Archives of Ophthalmology 1985; 103: 101–102
   PubMedGoogle Scholar
• Mueller D. W. Improved extemporaneous formulation of cyclosporine A ophthalmic drops. American Journal of Hospital Pharmacy 1994; 51: 3080–3081
   PubMedGoogle Scholar
• Oh C., Apel A. J., Saville B. A., Cheng Y. L., Rootman D. S. Local efficacy of cyclosporine in corneal transplant therapy. Current Eye Research 1994; 13(5)337–343
   PubMed Web of Science ®Google Scholar
• Oh C., Saville B. A., Cheng Y. L., Rootman D. S. A compartmental model of the ocular pharmacokinetics of Cyclosporine A in rabbits. Pharmaceutical Research 1995; 12(3)433–437
   PubMed Web of Science ®Google Scholar
• Pleyer U., Elkins B., Ruckert D., Lutz S., Grammer J., Chou J., Schmid K. H. Ocular absorption of cyclosporine A from liposomes incorporated into collagen shields. Current Eye Research 1994; 13(3)177–181
   PubMed Web of Science ®Google Scholar
• Reidv J. J., Gebhardt B. M., Kaufman H. E. The collagen shield: A new vehicle for delivery of cyclosporin A to the eye. Cornea 1990; 9(3)196–199
   PubMed Web of Science ®Google Scholar
• Sasamoto Y., Hirose S., Ohno S., Onoe K., Matsuda H. Topical application of ciclosporin solution containing α-cyclodextrin in experimental uveitis. Ophtalmologica 1991; 203: 118–125
   PubMed Web of Science ®Google Scholar
• Vernillet L., Keller H. P., Le Bigot J. F., Humbert H. Determination of cyclosporine in plasma: Specific Radioimmunoassay with a monoclonal antibody and Liquid chromatography compared. Clinical Chemistry 1989; 35(4)608–611
   PubMed Web of Science ®Google Scholar
• Vernillet L., Lundh R. L., Acezat-Mispelter F., Goizel C., Humbert H., Pouliquen Y. Ocular distribution of Cyclosporine (Sandimmun®) following systemic and topical administration to rabbits. European Journal of Drug Metabolism Pharmacy 1991; 3: 150–158
   Google Scholar
• Versura P., Cellini M., Zucchini P. G., Caramazza R., Laschi R. Ultrastructural and immunohistochemical study on the effect of topical cyclosporine in the rabbit eye. Cornea 1989; 8: 81–89
   PubMed Web of Science ®Google Scholar
• Wiederholt M., Kossendrup D., Schulz W., Hoffman F. Pharmacokinetics of topical cyclosporine A in the rabbit eye. Investigative Ophthalmology and Visual Science 1986; 27: 519–524
   PubMed Web of Science ®Google Scholar
• Zimmer A., Kreuter J., Robinson J. R. Studies on the transport pathways of PBCA nanoparticles in ocular tissues. Journal of Microencapsulation 1991; 8(4)497–504
   PubMed Web of Science ®Google Scholar